Dr Cinnie Soekojo is a consultant at the National University Cancer Institute, Singapore. She completed her internal medicine residency at the National University Hospital, Singapore, and obtained her post-graduate qualification from the Royal Colleges of Physicians, United Kingdom. She continued with her advanced specialty training in hematology at the National University Cancer Institute, Singapore, and obtained her Fellowship of the Royal College of Pathologists, United Kingdom. To further her training in multiple myeloma and cellular therapy, she completed a one-year advanced hematology fellowship in multiple myeloma, amyloidosis, and dysproteinemia at Mayo Clinic in Rochester, Minnesota, United States.
Her research interest is in the study of genomics, immune microenvironment, and the interaction between tumor and immune cells with single-cell sequencing and spatial omics. She did her postdoctoral research fellowship at the Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, and Harvard Medical School in Boston, Massachusetts, United States. She has published in several peer-reviewed journals and has also presented at regional and international meetings. She has received several awards and holds several grants for her research and is currently involved in clinical trials and translational research in her field of interest.
1. Soekojo CY, Kim K, Huang SY, Chim CS, Takezako N, Asaoku H, et al. Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network. Blood Cancer J. 2019;9(10):83.
2. Soekojo CY, Wang GM, Chen Y, Casan J, Wolyncewicz G, Lin A, et al. Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis. Clinical lymphoma, myeloma & leukemia. 2019;19(8):e470-e7.
3. Soekojo CY, Low JZ, Oh J, Ooi M, De Mel S, Chng WJ. Bacterial Infection Amongst Multiple Myeloma Patients Treated With Bortezomib- Based Induction Therapy: Real-World Experience in an Asian Cancer Center. Clinical Lymphoma Myeloma and Leukemia. 2020.
4. Soekojo CY, Ooi M, de Mel S, Chng WJ. Immunotherapy in Multiple Myeloma. Cells. 2020;9(3):601. Published 2020 Mar 3. doi:10.3390/cells9030601
5. Soekojo CY, Kumar SK. Stem-cell transplantation in multiple myeloma: how far have we come? Therapeutic advances in hematology. 2019;10:2040620719888111.
6. Soekojo CY, de Mel S, Ooi M, Yan B, Chng WJ. Potential Clinical Application of Genomics in Multiple Myeloma. Int J Mol Sci. 2018;19(6).
